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Differential effects of protein kinase B/Akt isoforms on glucose
homeostasis and islet mass
Abstract
Protein kinase B (PKB)/Akt is considered to be a key target downstream of insulin receptor substrate 2
(IRS2) in the regulation of beta-cell mass. However, while deficiency of IRS2 in mice results in diabetes
with insulin resistance and severe failure of beta-cell mass and function, only loss of the PKBbeta
isoform leads to a mild metabolic phenotype with insulin resistance. Other isoforms were reported not to
be required for metabolic regulation. To clarify the role of the three PKB isoforms in the regulation of
islet mass and glucose homeostasis, we assessed the metabolic and pancreatic phenotypes of Pkbalpha,
Pkbbeta or Pkbgamma -deficient mice. Our study uncovers a novel role for PKBalpha in the regulation
of glucose homeostasis, whereas it confirms that Pkbbeta (-/-) mice are insulin resistant with
compensatory increase of islet mass. Pkbalpha (-/-) mice displayed an opposite phenotype with
improved insulin sensitivity, lower blood glucose and higher serum glucagon concentrations.
Pkbgamma (-/-) mice did not show metabolic abnormalities. Additionally, our signalling analyses reveal
that PKBalpha, but not PKBbeta or gamma, is specifically activated by overexpression of IRS2 in
beta-cells and is required for IRS2 action in the islets.
PKB isoforms in glucose homeostasis  Buzzi et al. 
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Abstract 
 
Protein kinase B (PKB)/Akt is considered to be a key target downstream of insulin receptor 
substrate 2 (IRS2) in the regulation of -cell mass. However, while deficiency of IRS2 in 
mice results in diabetes with insulin resistance and severe failure of -cell mass and function, 
only loss of the PKB isoform leads to a mild metabolic phenotype with insulin resistance. 
Other isoforms were reported not to be required for metabolic regulation. To clarify the role 
of the three PKB isoforms in the regulation of islet mass and glucose homeostasis, we 
assessed the metabolic and pancreatic phenotypes of Pkb, Pkb or Pkb-deficient mice. Our 
study uncovers a novel role for PKB in the regulation of glucose homeostasis, whereas it 
confirms that Pkb-/- mice are insulin resistant with compensatory increase of islet mass. 
Pkb-/- mice displayed an opposite phenotype with improved insulin sensitivity, lower blood 
glucose and higher serum glucagon concentrations. Pkb-/- mice did not show metabolic 
abnormalities. Additionally, our signalling analyses reveal that PKB but not PKBor , is 
specifically activated by overexpression of IRS2 in -cells and is required for IRS2 action in 
the islets. 
PKB isoforms in glucose homeostasis  Buzzi et al. 
 
 
  3 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
Introduction 
 
Adaptation of pancreatic islet mass and function relative to metabolic demand maintains 
glucose homeostasis and may prevent the development of type 2 diabetes. -Cell 
proliferation, apoptosis, growth and function are tightly regulated by various extracellular 
factors and intracellular signalling pathways (23,24,34). In -cells, insulin receptor substrate 
(IRS) 2 controls maintenance and expansion of islet mass (29,31,42). In fact, IRS2-deficient 
mice are insulin resistant, show -cell failure, hyperglycaemia and finally develop diabetes 
(26,42). In contrast, deficiency for IRS1 only causes insulin resistance without the 
development of diabetes due to a compensatory increase in functional -cell mass (1,38). 
These observations indicated that IRS2, but not IRS1, is necessary for maintenance and 
compensatory increase of -cell mass. Furthermore, experiments with isolated islets revealed 
that overexpression of IRS2, but not of IRS1, can increase -cell proliferation and protect 
cells against high glucose-induced apoptosis (29). Downstream of IRS2, phosphoinositide 3-
kinase (PI3K)-protein kinase B (PKB) signalling is considered to be the critical pathway for 
the regulation of-cell mass and function (12,15,16,27). The serine-threonine kinase PKB, 
also known as Akt, is required for various cellular processes, from the regulation of cell cycle, 
survival and growth to glucose and protein metabolism. In mammals, three PKB/Akt isoforms 
have been characterised and named PKB/Akt1, PKB/Akt2 and PKB/Akt3. Although 
encoded by different genes on different chromosomes, the three isoforms display high 
homology at the protein level with 80-85% identical residues and the same structural 
organisation (43). However, they differ in terms of tissue-specific expression. PKB is 
expressed in most tissues, PKB is highly expressed in insulin responsive tissues, whereas 
PKB expression is prominent in brain and testes (17). All three isoforms are expressed in -
cells (30,37). The role of PKB in different tissues has been studied in transgenic mouse 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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models. While Pkb-/- and Pkb-/- mice show impaired foetal growth and brain development, 
respectively, glucose homeostasis is unaffected in both models (9,11,14,39,46). In contrast, 
Pkb-/- mice are insulin resistant, mildly glucose-intolerant and have less adipose tissue. 
Depending on strain and gender, these mice show either late loss of -cells followed by the 
development of diabetes and mild growth deficiency, or compensatory increase of -cell mass 
without age-dependent progression into overt hyperglycaemia (10,17). These studies 
suggested that PKB is the only isoform playing a role in the regulation of energy 
homeostasis. On the other hand, constitutive activation of PKB in -cells is sufficient to 
increase growth and proliferation (5,40), and in INS1 cells prevents FFA-induced apoptosis 
(44). Furthermore, antagonization of total PKB activity in -cells by ectopic expression of a 
kinase-dead mutant causes defects in insulin secretion (4), suggesting that in islets PKB is 
required mainly for normal function of the -cells. Although these data support the notion that 
PKB must play a role in pancreatic -cells, they are not in line with the stronger metabolic 
phenotype displayed by IRS2-deficient mice. In fact, PKB and  appear not at all to be 
required to regulate glucose homeostasis (9,11,39) and in the case of Pkb-/- mice, even 
though glucose homeostasis is impaired due to strong peripheral insulin resistance, overall 
metabolic phenotype is by far not as severe as in Irs2 -/- mice (10), indicating that the capacity 
for -cell compensation is retained in the absence of PKB. 
The aim of this study was to clarify the role of PKB in the regulation of islet mass and to 
define the relevance of PKB isoforms for IRS2 action in -cells. Although it had been shown 
that PKB is dispensable for regulation of glucose homeostasis (9,11), we found lower blood 
glucose concentrations in Pkb-/- mice. Based on this observation, we assessed in more detail 
the metabolic and the endocrine pancreatic phenotypes of Pkb, Pkb or Pkb-deficient mice. 
In addition, glucose uptake into fat cells, insulin secretion and islet cell proliferation were 
investigated. Contrary to previous assumptions, implying that PKB is the only (or at least the 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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main) isoform playing a role in the regulation of glucose metabolism, we present evidence 
that both PKB and  isoforms are required in the periphery for regulation of glucose 
homeostasis. While we confirmed that Pkb-/- mice are insulin resistant and glucose 
intolerant with compensatory increase of -cell mass, Pkb-/- mice showed lower blood 
glucose levels, were more insulin sensitive and revealed higher serum glucagon 
concentrations accompanied by a mild increase in -cell mass and proliferation. Moreover, 
our in vitro experiments show that PKB is specifically activated by IRS2 in -cells and that 
its activation is required for IRS2-induced proliferation in islets. 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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Materials and methods 
 
Animals 
Mice deficient for the PKB isoforms (Pkb-/-, Pkb-/- and Pkb-/- mice) were previously 
generated and described (13,39,46). Pkb-/- and Pkb-/- mice were on a mixed 129/Ola and 
C57BL/6 genetic background, Pkb-/- on a mixed 129/SvJae and C57BL/6 background. Male 
and female mice at two different age points (two to three and five to six months old) have 
been investigated, comparing PKB-deficient mice with wild type littermates. Data presented 
are from five to six months old male mice, unless otherwise noted, since the younger age 
group and the females displayed a similar phenotype. Mice were housed according to the 
Swiss Animal Protection Laws in groups with 12-h dark-light cycles and with free access to 
food and water. All procedures were conducted with the relevant approval of the appropriate 
authorities. 
 
Determination of glucose, insulin, glucagon and corticosterone 
A blood sample was collected from the tail vein of mice, and D-glucose was measured using a 
glucose meter (FreeStyle, Disetronic Medical System AG, Burgdorf, Switzerland). After 
sacrificing the animals, blood was collected by cardiac puncture using an insulin syringe (BD 
Micro Fine, BD Consumer Healthcare, Le Pont de Claix, France) and supplemented with 
Aprotinin (Sigma-Aldrich, Saint Louis, Missouri, USA). After centrifugation, the serum was 
immediately frozen. Insulin and glucagon were measured with the Mouse Endocrine 
multiplex Kit from Linco (Linco Research, St.Charles, Missouri, USA). Alternatively, an 
ELISA Kit (Ultra Sensitive Rat Insulin ELISA Kit, Crystal Chem, Downers Grove IL, USA) 
was used to measure insulin. Corticosterone was measured with the Corticosterone Double 
Antibody RIA Kit (MP Biomedicals, Eschwege, Germany). For all experiments, blood 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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samples for metabolic parameters were drawn at the same time of the day, in the morning (9-
11 a.m.). 
 
Oral glucose tolerance tests (GTT), intraperitoneal insulin tolerance tests (ITT) and 
intraperitoneal glucagon challenge (GC) 
For GTT and ITT, mice were fasted overnight. D-Glucose was orally administered at 2 g/kg 
weight (D-(+)-glucose anhydrous, Fluka, Buchs, Switzerland). Insulin was administered by 
injection (IP) at 0.75 U/kg weight (human recombinant insulin, Sigma-Aldrich, Saint Louis, 
Missouri, USA). For GC, mice were fasted 8 hours and glucagon was administered by 
injection (IP) at 30 g/kg weight (GlucaGen, Novo Nordisk Pharma, Bagsværd, Denmark). 
Tail blood was collected at the times indicated and D-glucose levels determined as described 
above. 
 
Morphometric analysis of the pancreatic islets 
Pancreata were dissected, fixed in zinc formalin, embedded in paraffin and cut into 3 m 
sections. To assess the size and number of islets and of -cells and -cells three sections per 
pancreas were stained for insulin (mouse monoclonal antibody, Sigma-Aldrich, Saint Louis, 
Missouri, USA) and glucagon (rabbit polyclonal antibody, DAKO, Glostrup, Denmark). 
Fluorescent secondary antibodies against mouse (FITC) and rabbit (Cy3) were purchased 
from Jackson ImmunoResearch Laboratories (West Grove, Pennsylvania, USA). Stained 
sections were analysed using Axioplan 2 and Axio Vision software (Zeiss, Göttingen, 
Germany). The area of the whole sections was assessed with Image J (National Institutes of 
Health, Bethesda, Maryland, USA). To visualize proliferating - and -cells, Ki-67 
immunostaining (goat polyclonal antibody, Santa Cruz Biotechnology, Santa Cruz, 
California, USA) was used (19) in combination with DAPI (Sigma-Aldrich, Saint Louis, 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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Missouri, USA) and insulin or glucagon staining, respectively. Apoptosis was assessed with 
ApopTag  Peroxidase in situ Detection Kits (Q-Biogene, Montreal, Quebec, Canada). ®
 
Islet isolation and culture 
Islets were isolated from 5-months old wild type and PKB-deficient mice by collagenase 
(Worthington Biochemical Corporation, Lakewood, USA) digestion of the pancreas, as 
previously described (36). After a density gradient (Histopaque-1119, Sigma-Aldrich, Saint 
Louis, Missouri, USA) and handpicking for further purification, the islets were cultured in 
RPMI 1640 medium containing 11.1 mmol/l D-glucose (Invitrogen, Carlsbad, California), 
10% FCS (Hyclone Laboratories Inc., Logan, Utah, USA), 100 units/ml penicillin, 100 g/ml 
streptomycin and 40 g/ml gentamycin (Invitrogen, Carlsbad, California, USA). Islets were 
plated on plates coated with extracellular matrix (ECM) derived from bovine corneal cells 
(Novamed, Jerusalem, Israel) and allowed to attach and flatten for three days before the start 
of the experiments. 
 
Insulin secretion and proliferation assays in isolated islets 
To assess glucose-stimulated insulin secretion, 24 islets of similar size per dish were 
incubated for 1 hour in the presence of 2.8 mM glucose and subsequently stimulated for 1 
hour with 16.7 mM glucose. Overnight acid-alcohol extraction was used to collect total 
insulin and protein contents. Secreted insulin and total insulin content were measured using 
the Mouse Insulin ELISA Enzyme immunoassay (Mercodia, Uppsala, Sweden) and 
normalised by protein content, as measured using the Bicinchoninic Acid Assay (BCA) 
(Pierce, Rockford, USA). The BrdU Labeling and Detection Kit II (Roche, Basel, 
Switzerland) combined with insulin (guinea-pig antibody, DAKO, Glostrup, Denmark) and 
DAPI staining was used to assess proliferation in -cells. Islets were incubated for two days 
in the presence of BrdU. 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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RNA extraction from isolated islets and Real Time PCR 
Total RNA was extracted from 80 mouse islets using the Nucleospin RNAII Kit (Macherey-
Nagel GmBH, Dueren, Germany) and reverse transcribed using SuperScriptTM II reverse 
transcriptase and random hexamers as primers (Invitrogen, Carlsbad, California, USA). Real 
Time PCR primers for actin, Pkb, Pkb, Pkb and Glut2 were supplied by Applied 
Biosystems (Foster City, California, USA) and changes in mRNA expression were calculated 
using the difference of cycle threshold values, as previously described (36). 
 
Fat cell isolation and glucose uptake 
Isolation of white adipocytes from 5-months old wild type and Pkb-/- mice and glucose 
incorporation experiments were performed as described previously (35,45). Adipocytes were 
incubated in Kreb's Ringer buffer containing 1% BSA in the presence of D-[U-14C]glucose 
with or without 100 nM insulin for 1 hour. The radioactivity in lysates was measured by 
liquid scintillation counting (Kontron Betamatic V, Kontron Instruments, Montigny-Le-
Bretonneux, France). Glucose uptake was normalised by number of adipocytes. 
 
Cell culture 
Rat Insulinoma INS1 cells (2) clone 832/13 (21) were cultured in RPMI 1640 medium 
containing 11 mmol/l D-glucose, supplemented with 10% FCS (fetal calf serum), 100 U/ml 
penicillin, 100 g/ml streptomycin, 2 mM glutamax, 1 mM sodium pyruvate, 10 mM HEPES 
and 50 M -mercaptoethanol (Invitrogen, Carlsbad, California, USA). 
 
Adenoviral gene transfer into islets and INS1 cells 
Adenoviral vectors encoding myc-tagged IRS1, IRS2 or GFP have been described previously 
(29). Adenoviral vectors encoding HA-tagged PKB, PKB or GFP were supplied by Vector 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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BioLabs (Philadelphia, Pennsylvania, USA). After three days of culture on ECM plates islets 
were exposed to viral particles for two days at a multiplicity of infection (MOI) of 1500-3000. 
INS1 cells were transfected at about 80% of confluence and an MOI of about 10. Viral 
particles were removed after six hours by changing medium. After two days, cells were 
pelleted in PBS by centrifugation and immediately frozen in liquid nitrogen. 
 
Immunoprecipitation and Western blotting 
INS1 cell pellets were lysed in a buffer containing 50 mM HEPES, 140 mM NaCl, 
0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 3 μg/ml leupeptin, 3 μg/ml 
aprotenin, 10 mM sodium fluoride, 1 mM disodium pyrophosphate and 1 mM sodium 
orthovanadate. The BCA assay was used to measure protein concentrations in the lysates. 
500 g of protein were incubated overnight with the respective antibody. Serum obtained 
from rabbits immunized with PKB isoform-specific peptides (13,39,46) was used for 
immunoprecipitation. After three hours incubation with Protein A beads (rpm Protein A 
Sepharose Fast Flow, GE Healthcare, Buckinghamshire, England), bound beads were washed 
several times with lysis buffer. Proteins bound to beads were finally dissociated by heating for 
3 minutes at 70°C in NuPAGE LDS Sample Buffer with Sample Reducing Agent (Invitrogen, 
Carlsbad, California, USA). Eluates were frozen for later analysis. Equal amounts of lysates 
and eluates were loaded on NuPAGE Novex 4-12% Bis-Tris Gels (Invitrogen, Carlsbad, 
California, USA) and transferred onto Hybond-P PVDF membranes (Amersham, GE 
Healthcare, Buckinghamshire, England). The membranes were incubated overnight at 4°C 
with primary antibody and 1h at room temperature with secondary antibody. Signals were 
visualised with Lumi-Light Western Blotting Substrate (Roche, Basel, Switzerland) and 
quantified using LAS-3000 AIDA software (Fujifilm, Tokio, Japan). Antibodies against total 
PKB, phospho-PKB (Ser 473 mouse monoclonal / rabbit polyclonal), PKB and PKB were 
purchased from Cell Signalling Technology (Beverly, Massachusetts, USA). Additionally we 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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used antibodies against PKB (BD Bioscience, Franklin Lakes, New Jersey, USA), actin 
(Millipore-Chemicon International, Billerica, Massachusetts, USA), IRS1 (Santa Cruz 
Biotechnology, Santa Cruz, California, USA), IRS2 (Millipore-Upstate, Billerica, 
Massachusetts, USA) and myc (self-produced). Secondary antibodies against mouse (Santa 
Cruz Biotechnology, Santa Cruz, California, USA) and rabbit (BioRad, Hercules, California, 
USA) were used. 
 
Statistical analysis 
Data are provided as means ± SEM. Unpaired Student's t-tests (two-tailed) were performed 
for comparison between data from wild type and PKB deficient mice with Welch’s correction 
in case of significantly different variances. ANOVA with Bonferroni’s post hoc test was used 
for multiple comparison analysis. Results with P values under 0.05 were considered 
statistically significant. 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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Results 
 
PKB is required for regulation of glucose homeostasis 
To investigate whether PKB plays a role in regulation of glucose homeostasis, we examined 
metabolic parameters of Pkb-deficient mice. Pkb-/- animals weighed less compared to 
control littermates (-14.5 ± 1.5%, Fig. 1A). In contrast to previously published data (9,11), we 
found significantly lower blood glucose (-21.2 ± 4.5%, Fig. 1B) and higher serum glucagon 
concentrations (+219 ± 97.3%, Fig. 1D) in Pkb-/- mice (random fed) compared to wild type 
littermates. Serum insulin (random fed, Fig. 1C) and serum corticosterone (Fig. 1E) 
concentrations were not significantly increased in Pkb-/- mice. Presented data refer to male 
mice, and females showed similar metabolic values (data not shown). 
Next we assessed metabolic response in Pkb-/- and wild type littermates. During oral 
glucose tolerance tests (GTT) blood glucose levels remained consistently lower in Pkb-/- 
with a significant reduction in the area under the curve (-46.5 ± 12.3%, Fig. 2A). 
Intraperitoneal insulin tolerance tests (ITT) revealed lower levels of blood glucose in Pkb-/- 
mice after insulin administration with a significant reduction of the area under the curve (-
54.2 ± 14.3%, Fig. 2B). During intraperitoneal glucagon challenge (GC) all animals showed a 
similar increase in blood glucose concentration after glucagon injection but a more rapid 
decrease was observed in Pkb-/- compared to control mice (Fig. 2C). We also assessed 
glucose incorporation into adipocytes isolated from peri-gonadal epididymal fat. As shown in 
Fig. 2D, insulin-induced glucose incorporation was significantly higher (+81.9 ± 31.0%) in 
adipocytes from Pkb-/- mice than from control littermates. No difference was found in 
adipocyte cell size (Fig. 2E). Additionally, we measured glucose-stimulated insulin secretion 
from isolated islets. Compared to islets from control littermates, insulin secretion from Pkb-
/- islets was higher after stimulation with glucose (+202.0 ± 146.4%, Fig. 3A), whereas basal 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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values were similar. Glut2 expression in islets was not changed and could therefore not 
explain this improvement (Fig. 3C). No significant increase in total insulin content was found 
between controls and Pkb-/- islets (Fig. 3B). 
Islet morphology was analysed by staining pancreatic sections for insulin, glucagon and the 
proliferation marker Ki-67. Pancreatic sections from Pkb-/- mice consistently revealed a 
trend towards increased -cell area (1.52 ± 0.3 fold, Fig. 4D) as well as proliferation (1.85 ± 
0.6 fold, Fig. 4F-H). In contrast, islet area (Fig. 4A) and proliferation of -cells (Fig. 4C) were 
unchanged compared to control animals (1.04 ± 0.14 and 0.92 ± 0.18 fold, respectively). Size 
of -cells (Fig. 4E) and -cells (Fig. 4B) was unchanged. In females, similar results were 
found but no increase in -cell area (data not shown). 
Expression of PKB and PKB was assessed in liver, skeletal muscle, fat and islets isolated 
from Pkb-deficient mice and controls. No difference between controls and Pkb-/- mice was 
observed (Supplementary fig. 1). 
 
Different role for PKB in regulation of glucose homeostasis and insulin sensitivity 
Pkb-/- mice weighed less compared to control littermates (-18.2 ± 1.6%, Fig. 5A). Analysis 
of metabolic parameters showed significantly higher blood glucose and serum insulin 
concentrations for Pkb-/- mice (random fed) compared to control littermates (+63.8 ± 4.2%, 
Fig. 5B and +306.0 ± 55.9%, Fig. 5C, respectively). Serum glucagon levels were not 
significantly changed (Fig. 5D). GTT and ITT have previously been performed with Pkb-/- 
mice from this strain and revealed glucose and insulin intolerance (13). Analysis of pancreas 
morphology in Pkb-/- mice revealed significantly increased islet area (2.4 ± 0.3 fold, Fig. 
6A,G-H) as well as proliferation of -cells (1.9 ± 0.2 fold, Fig. 6C,I-J), while -cell area (Fig. 
6D) and proliferation (Fig. 6F) were unchanged. No changes were found in - (Fig. 6B) and 
- (Fig. 6E) cell size. Similar phenotype was found for female mice, although increases in 
PKB isoforms in glucose homeostasis  Buzzi et al. 
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blood glucose, serum insulin and glucagon were milder than in the males and not significant 
(data not shown). PKB and PKB expression was analysed in islets of Pkb-/- and control 
mice and showed no significant differences (Supplementary fig. 2). 
 
PKB is dispensable for regulation of glucose homeostasis 
Pkb-/- male and female mice showed no differences in body weight (Fig. 7A) and blood 
glucose concentrations (random fed, Fig. 7B) compared to their wild type littermates, 
confirming previously published results (14,39). GTT and ITT for Pkb-/- mice have been 
previously performed and revealed no changes (13). Analysis of pancreas morphology of 
Pkb-/- males and females showed normal - (Fig. 7C) and - (Fig. 7E) cell area, as well as 
no changes in - (Fig. 7D) and - (Fig. 7F) cell size. 
 
PKB acts downstream of IRS2 in the -cells 
We wanted to analyse which isoforms of PKB are specifically activated by IRS2 in -cells. In 
line with published data (28,32), we found that PKB was strongly activated after 
overexpression of IRS2 (5.1 ± 0.9 fold, Fig. 8A), while induction of PKB phosphorylation by 
IRS1 was only mild and restricted to certain conditions (i.e. starvation of the cells prior to 
virus transfection, data not shown). To analyse activation of the individual PKB isoforms we 
performed immunoprecipitations with isoform-specific antibodies and subsequently detected 
phosphorylation of PKB in immunoprecipitates by Western blotting. This procedure was 
necessary, as antibodies against specific phosphorylated PKB isoforms are not available. As 
shown in Fig. 8B and 8E, PKB was specifically activated by overexpression of IRS2 (3.7 ± 
0.7 fold increase relative to GFP). No phosphorylation was detected for PKB (Fig. 8C, E). 
However, we were able to detect specific activation of PKB but not PKB after stimulation 
of adipocytes with insulin (data not shown) indicating that the antibody against PKB used in 
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our study is functional. Finally, PKB was activated by overexpression of IRS2 (1.7 ± 0.5 fold 
increase), but far less compared to PKB and with higher variability between the experiments 
(Fig. 8D,E). 
 
PKBis required and sufficient for induction of proliferation in -cells  
To investigate if PKB isoforms are required for IRS2 action in -cells, we overexpressed 
IRS2 in islets isolated from Pkb -/- mice and determined the proliferation rate. In control islets 
derived from Pkb+/+ mice and overexpressing IRS2 we found a strong increase in cell 
proliferation (13.2 ± 0.6 fold, Fig. 9A left). In islets isolated from Pkb-/- mice basal values 
were similar to control, but the increase in proliferation induced by IRS2 (10.4 ± 1.1 fold) was 
reduced by 27.1 ± 2.82% (Fig. 9A right). In islets of Pkb+/+ mice IRS2 induced an increase 
in proliferation of 3.3 ± 0.5 fold (Fig. 9B left) very similar to islets isolated from Pkb-/- mice 
(3.6 ± 1.2 fold, Fig. 9B right).  To examine whether PKB isoforms are also sufficient to 
induce proliferation in islets, PKB or PKB, respectively, were overexpressed in islets 
isolated from wild type C57BL/6 mice. Overexpression of PKBbut not of PKB resulted 
in a significant increase in cell proliferation (3.1 ± 0.36 fold, Fig. 9C). 
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Discussion 
 
In -cells PKB/Akt is considered to be an important downstream mediator of IRS2 in the 
regulation of islet mass, however, available data are contradictory. Our study was designed to 
re-evaluate the relevance of PKB in the control of blood glucose homeostasis and to clarify its 
role in the regulation of islet mass downstream of IRS2 with a focus on the single isoforms. 
This included an investigation of metabolic parameters and pancreas morphology in mice 
deficient for PKB,  or  isoforms, respectively, as well as in vitro signalling analyses. We 
discovered a novel role for PKB in the regulation of insulin sensitivity. In addition PKB 
was found to be the major isoform in -cell signalling downstream of IRS2. While PKB 
isoforms are individually dispensable for regulation of maintenance of islet mass, PKB may 
mediate IRS2-dependent compensation of functional -cell mass. 
Metabolic phenotypes differed in the three isoform-specific PKB-deficient mouse strains. 
Interestingly, we discovered a previously undescribed phenotype for Pkb-/- mice in addition 
to growth retardation, which was (at least in part) ascribed to defects in placental development 
(46,48). We found that Pkb-/- mice displayed significantly lower blood glucose and 
increased serum glucagon concentrations and responded better to insulin, indicating that they 
are more glucose tolerant and more insulin sensitive than their wild type littermates (Fig. 2). 
Improved insulin action was also reflected by increased insulin-stimulated glucose uptake into 
isolated adipocytes. Since the level of PKBin insulin-sensitive tissues as well as in islets did 
not differ between Pkb-/- and control mice (Supplementary fig. 1), we can exclude that the 
observed metabolic phenotype is due to a compensatory increase of the PKB isoform. Our 
results contrast previous work suggesting normal glucose homeostasis in Pkb-/- mice (9,11), 
although also in the study by Cho et al. a trend towards improved glucose tolerance and 
insulin sensitivity in Pkb-/- mice was apparent. These differences might indicate that the 
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expressivity and penetrance of this phenotype is sensitive to genetic background and might 
differ among the individuals, as was previously described for Pkb-/- mice where high 
variability was found not only between different strains but also among mice of the same 
strain (17). The mice investigated in our study as well as by Cho et al. were on a mixed 129 
Ola and C57BL/6 background (although belonging to separate strains), while data published 
by Chen et al. refer to mice on a 50% 129 R1 and 50% C57BL/6 genetic background. 
Whereas serum insulin, islet area and -cell proliferation were similar in Pkb-/- mice relative 
to control littermates, serum glucagon as well as -cell area and -cell proliferation were 
increased in the majority of investigated animals. To the best of our knowledge, this is the 
first study describing glucagon sensitivity and level in serum as well as the islet phenotype of 
Pkb-/- mice. Improved insulin sensitivity could lead to the observed decrease in blood 
glucose levels and compensatory rise in serum glucagon and corticosterone. In this case, 
however, insulin secretion would be expected to be downregulated, while we observed normal 
or even increased serum insulin concentration in Pkb-/- mice. This rather suggests a primary 
-cell defect and a deregulation of insulin secretion relative to metabolic needs. However, 
lower blood glucose, increased serum glucagon, -cell hyperplasia together with improved 
glucose tolerance were also observed in glucagon receptor knock out mice (18,33). It could 
therefore be that the phenotype of Pkb-/- mice is caused by defective glucagon signalling. 
Nevertheless, after intraperitoneal administration of glucagon we observed a similar increase 
in blood glucose concentration suggesting that Pkb-/- and control mice are similarly 
sensitive to glucagon. The following more rapid decrease in blood glucose in Pkb-/- mice is 
probably attributable to the improved insulin sensitivity. Since our mouse model is a whole 
body knock out, we can not exclude that the observed phenotype both metabolically and in 
terms of pancreas morphology is due to secondary effects. However, the fact that glucose 
uptake was also improved in isolated fat cells and insulin secretion from isolated islets was 
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enhanced rather suggests a cell-autonomous effect of PKB absence. To conclusively address 
this question, tissue-specific knock out for PKB in-cells or in specific insulin-target tissues 
(i.e. fat tissue, skeletal muscle and liver) would be required. 
Pkb-/- mice showed a distinct phenotype from Pkb-/- mice. Despite being smaller than their 
control littermates, blood glucose and serum insulin concentrations were increased, consistent 
with previous studies showing that deficiency for PKB leads to insulin resistance (13). We 
also investigated in more detail pancreas morphology, as neither -cell phenotype nor -cell 
proliferation had been described yet. We found a compensatory increase in islet mass with 
concomitant increase in -cell proliferation, while -cell area and proliferation were 
unchanged relative to wild type littermates. In contrast to -cell proliferation, -cell size was 
unchanged indicating that the increase in -cell mass is due to hyperplasia rather than 
hypertrophy. Expression of remaining PKB isoforms was not changed in islets of Pkb-/- 
mice indicating that the increase in islet mass is not due to a compensatory increase of PKB 
expression (Supplementary fig. 2). Our results are in line with the findings by Cho et al. (10), 
though we also found a decrease in body mass, as described by Garofalo et al. (17), thus 
confirming that the  isoform of PKB is required for both glucose metabolism and growth. 
Although both PKB and  are required to control growth, they seem to have opposite roles 
in the regulation of glucose homeostasis. While PKB improves insulin sensitivity in the 
periphery, PKB appears to decrease it. Finally, we found no difference regarding metabolic 
parameters and pancreas morphology in Pkb-/- mice compared to control littermates, 
confirming published reports showing a dispensable role for PKB in glucose metabolism 
(14,39). 
As PKB function is thought to be required for IRS2-dependent regulation of islet mass 
(12,15,16,27), we assessed activation/phosphorylation of the PKB isoforms downstream of 
IRS2. As shown by Lingohr et al. (28), we confirmed a strong (five-fold) induction of PKB 
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phosphorylation in -cells overexpressing IRS2, but not IRS1. Analysis of activation of the 
single PKB isoforms revealed that PKB was specifically activated by IRS2, whereas 
activation of PKB was weak and inconsistent. Interestingly, PKB was not activated in -
cells after overexpression of IRS2 (Fig. 8). This implies that in -cells IRS2 signalling occurs 
mainly via PKB, whereas PKB does not play a major role downstream of IRS2. Such 
specific activation suggests distinct non-redundant roles for PKB isoforms in -cell 
signalling, in line with previous findings showing isoform-specific activation and functions 
for PKB downstream of IRS in other tissues (3,7,22,47). 
As described previously, IRS2, but not IRS1, can induce a strong increase in cell proliferation 
in isolated islets (29). To address the question whether the observed specific activation of 
PKB is required for IRS2 action in -cells, we analysed the enhancement of cell 
proliferation in isolated islets overexpressing IRS2 and deficient for PKB or . Our results 
indicate that PKB is required downstream of IRS2 in islets, as the IRS2-induced increase in 
cell proliferation was significantly reduced in islets deficient for PKB (Fig. 9). Induction of 
proliferation was, however, only 27% abrogated, indicating that other signalling targets in 
addition to PKB must be required for full induction of proliferation by IRS2. Proliferation 
was similar in control islets and Pkb-/- islets after transfection with AdV-GFP, implying that 
the proliferation rate under basal conditions does not depend on PKB. Requirement for 
PKB agrees well with our observation that PKB is specifically activated by overexpression 
of IRS2 but not of IRS1. In contrast, we observed a similar IRS2-induced increase of 
proliferation in control and Pkb-/- islets suggesting that PKB is not required downstream of 
IRS2, which is in line with the finding that overexpression of IRS2 does not activate PKB. 
Although IRS2-induced proliferation does not reach the same extent as in Pkb-/- islets, 
implying a potential role of PKB in this action, basal proliferation is also reduced compared 
to the controls and could thus explain this difference. The very low proliferation rates found 
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in isolated Pkb-/- islets cultured on ECM plates suggests that Pkb-/- islets might suffer from 
a growth disadvantage on this matrix. In fact, even higher -cell proliferation was found in 
pancreatic sections of Pkb-/- mice. PKB was shown to be required for growth of pancreatic 
islets on ECM (6,20,25,41) and this observation suggests that PKB could be the responsible 
isoform. This hypothesis is supported by the finding that proliferation in Pkb-/- islets can be 
significantly increased after adenoviral re-expression of the PKB isoform (data not shown). 
We observed differences in basal proliferation rates between Pkb+/+ and Pkb+/+ islets. 
Because the levels of basal proliferation also varied within strains between experiments these 
differences were probably due to experimental variations such as islet isolation. Nevertheless, 
the relative differences and induction rates were consistently maintained within the strains. 
Finally, the prominent role played by PKB in the regulation of -cell proliferation is 
supported by our finding that overexpression of this isoform, but not of PKB, in isolated 
wild type islets is sufficient to significantly increase cell proliferation (Fig. 9C). 
We recently proposed that maintenance and compensatory expansion of islet mass may be 
regulated by separate pathways downstream of IRS2 (31). It was predicted that PKB is 
dispensable for maintenance of -cell mass, whereas PKB might mediate expansion of islet 
mass. The results of the present study are fully compatible with this model and support the 
idea that none of the three PKB isoforms are required to maintain islet mass, as in none of the 
isoform-specific PKB-deficient strains islet mass was decreased, but in the case of Pkb-/- 
mice even increased. As others have shown previously, islet mass was not affected even after 
80% of PKB activity was removed in -cells (4), indicating that redundancy between 
isoforms is an unlikely explanation for the mild phenotype found in isoform-specific PKB-
deficient mice. Consistently, absence of one isoform does not lead to compensatory 
upregulation of the remaining two isoforms in any of the tissues analysed by us 
(Supplementary fig. 1 and 2) as well as in previous studies (11,17,39,46). In combination with 
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previous data, showing that constitutive activation of the  isoform is sufficient to increase -
cell growth and proliferation (5,40), our results support the notion that PKB contributes to 
compensatory increase of functional islet mass. The recent discovery that heterozygosity for 
PKB converts the mild metabolic phenotype of Pkb-/- mice into overt type 2 diabetes with 
prominent -cell dysfunction supports our findings implying an important role played by 
PKB in glucose homeostasis and in particular in -cell function (8). 
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Figure legends 
 
Figure 1. PKB is required for metabolic regulation. Body weight (A), blood glucose (B), 
serum insulin (C), serum glucagon (D) and serum corticosterone (E) concentrations were 
examined in random fed Pkb-/- mice (filled bars) and control littermates (open bars). Data 
are presented as mean ± SEM with n=9-15. Results are from 5-6 months old male mice. 
Similar results were obtained in younger mice (2-3 months old) and in females (data not 
shown). *, P<0.05; ***, P<0.001. 
 
Figure 2. Pkb -/- mice are more insulin sensitive. (A-B) Curves represent blood glucose 
concentration during 180 min oral glucose tolerance test (GTT) (A) and intraperitoneal insulin 
tolerance test (ITT) (B) in Pkb -/- mice (closed squares) and control animals (open squares). 
Results are mean ± SEM of n=3-7 and are from 5-6 months old male mice. Same trends were 
found in younger animals (2-3 months old) and in females. Bar graphs to the right show the 
respective area under the curve (AUC) of GTT and ITT, respectively. (C) Blood glucose 
concentration during 60 min intraperitoneal glucagon challenge (GC) in Pkb -/- (closed 
squares) and control male mice (open squares). Data are mean ± SEM of n=4-5. Female mice 
showed similar results (data not shown). (D) Glucose uptake measured after insulin 
stimulation (100 nM) of perigonadal fat cells isolated from Pkb -/- female mice (filled bars) 
and control littermates (open bars). Adipocyte size is shown in (E). Data are presented as 
mean ± SEM of n=5-6. *, P<0.05; **, P<0.01. 
 
Figure 3. Insulin secretion in islets isolated from Pkb -/- mice. Glucose-stimulated insulin 
secretion (A) and total insulin content (B) in islets isolated from Pkb -/- female mice (filled 
bars) and control littermates (open bars). Data are presented as mean ± SEM of n=3-8. Glut2 
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mRNA expression (C) in islets isolated from Pkb -/- female mice (filled bars) and control 
littermates (open bars). Data are means ± SEM of n=5. 
 
Figure 4. Pancreatic phenotype of Pkb -/- mice. Pancreatic sections of Pkb-/- mice were 
immuno-stained for insulin and glucagon and islet morphology was analysed. -Cell area (A) 
and size (B) as well as -cell area (D) and size (E) in sections of Pkb-/- mice (filled bars) are 
shown compared to the respective controls (open bars). Expression of Ki-67 was assessed to 
visualize proliferating cells. Ki-67-positive -cells (C) and -cells (F) (insulin and glucagon 
positive, respectively) are normalized by - and -cell area, respectively. (G-H) 
Representative pancreatic sections of Pkb+/+ and Pkb-/- mice co-stained for glucagon 
(dark red cells) and Ki-67 (brown nuclei, arrow). Data are means ± SEM of n=6 and results 
are from 5-6 months old male mice. Females showed similar results but no increase in -cell 
area (data not shown). 
 
Figure 5. Metabolic parameters in Pkb -/- mice. Analysis of body weight (A), blood 
glucose (B), serum insulin (C) and serum glucagon (D) concentrations in random fed Pkb-/- 
mice (hatched bars) and control littermates (open bars). Data are means ± SEM of n=11-22. 
Results are from 5-6 months old male mice. Similar results were obtained with younger mice 
(2-3 months old), whereas females showed milder and not significant increase in blood 
glucose and serum insulin (data not shown). ***, P<0.001. 
 
Figure 6. Pancreatic phenotype of Pkb -/- mice. -Cell area (A) and size (B),-cell area 
(D) and size (E), Ki-67 positive -cells (C) and -cells (F) in pancreatic sections of Pkb-/- 
mice (hatched bars) compared to controls (open bars). (G-H) Representative sections of 
Pkb+/+ and Pkb-/- mice stained for insulin (green), glucagon (red) and DNA (DAPI, blue). 
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(I-J) Representative sections co-stained for insulin (red) and Ki-67 (brown nuclei, arrows). 
Data are presented as mean ± SEM of n=6-7. Results are from 5-6 months old male mice. 
Same results were obtained with younger mice (2-3 months old) and in females (data not 
shown). *, P<0.05; **, P<0.01. 
 
Figure 7. PKB is dispensable for regulation of glucose homeostasis. Body weight (A) and 
blood glucose concentration (B) in random fed Pkb-/- mice (checked bars) compared to 
littermate controls (open bars).-Cell area (C) and size (D), and -cell area (E) and size (F) 
in pancreatic sections of Pkb-/- mice (checked bars) compared to controls (open bars). Data 
are presented as mean ± SEM of n=24 for metabolic parameters and n=6 for morphologic 
analysis. Results are from 2-3 months old male mice. Same results were obtained with 
females (data not shown). 
 
Figure 8. PKB acts downstream of IRS2 in -cells. (A) Western blot analysis showing 
phosphorylation of PKB after adenoviral overexpression of myc-tagged IRS1 and IRS2, 
respectively, in INS1 cells. Endogenous expression of PKB was assessed for normalization. 
As control, cells were transfected with AdV-GFP. Signals of 7 independent experiments were 
quantified and the mean increase in phosphorylation in % of control is presented as a bar 
graph on the right. As the antibody against phosphorylated PKB detects all three isoforms, 
signals in the lysates are not isoform-specific. (B-E) To analyse activation of PKB isoforms, 
lysates of INS1 cells overexpressing IRS2 were immunoprecipitated with isoform-specific 
antibodies. Representative Western blots for PKB B), PKB (C) and PKB (D), 
respectively, are shown. Signals for phosphorylated PKB were normalized to signals of the 
respective non phosphorylated PKB PKB or PKB isoform. For detection of PKB and 
PKB all available antibodies were raised in rabbit, thus it was not possible to avoid signal of 
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PKB(left) and PKB (right) after overexpression of GFP (light grey) or IRS2 (dark grey). 
Data are represented as % of control. **, P<0.01; ***, P<0.001. 
 
Figure 9. PKB is required for induction of proliferation by IRS2 in -cells. Cell 
proliferation was assessed in isolated islets after adenoviral transfection with IRS2-, PKB-, 
PKB- or GFP-encoding vectors. As the islets were counterstained for insulin, the positive 
cells represent -cells (although occasionally other islet cells may have been counted). (A-B) 
Graphs show the percentage of BrdU-positive cells of total number of cells in islets isolated 
from Pkb -/- (A) and Pkb -/- (B) female mice and respective controls after overexpression of 
GFP (light grey) and IRS2 (dark grey). Values are mean ± SEM of n=3-5. (C) Graph shows 
the percentage of BrdU-positive cells in islets isolated from wild type C57BL/6 male mice 
after overexpression of GFP (light grey), PKB (dark dotted) and PKB (light dotted). 
Values are mean ± SEM of n=6. Equal adenoviral expression was tested in parallel 
experiments in INS1 cells (data not shown).  *, P<0.05; ***, P<0.001. 
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Supplementary Methods 
 
 
Organ lysates and Western blotting 
Liver, femoral muscle and perigonadal fat pads were dissected and homogenised in a buffer 
containing 50 mM Tris HCl, 40 mM beta-glycerolphosphate, 120 mM NaCl, 1% NP40, 10% 
glycerol, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 3 μg/ml leupeptin, 3 μg/ml aprotenin, 
10 mM sodium fluoride, 1 mM disodium pyrophosphate and 1 mM sodium orthovanadate. Protein 
concentrations in the lysates were determined by the BCA assay and Western blotting was 
performed as described in the Methods section. 
 
 
Supplementary Figure Legend 
 
Supplementary figure 1. Expression of PKB isoforms in Pkb -/- tissues. 
(A) Western blot analysis showing expression of PKB in skeletal muscle, fat and liver from Pkb -
/- and wild type mice. Actin was detected for normalization. To control for the isoform specificity of 
the antibody, protein expression was analysed in lysates of brain extracted from Pkb -/- (C1) and 
Pkb +/+ (C2) mice. Six mice per group were analysed. Signals were quantified and the mean 
expression in % of control is presented as a bar graph below. PKB could not be detected by 
immunoblotting (data not shown) except in the brain controls, confirming the low expression of this 
isoform in metabolic tissues. (B) Real Time PCR analysis showing mRNA expression of Pkb and 
Pkb in islets isolated from Pkb -/- (filled bars) and control mice (open bars). The results were 
normalised to actin mRNA levels. Data are presented in % of control (mean ± SEM of n=5-9). 
 
 
Supplementary figure 2. Expression of PKB isoforms in Pkb -/- islets. 
Real Time PCR analysis showing mRNA expression of Pkb and Pkb in islets isolated from Pkb 
-/- (hatched bars) and control mice (open bars). The results were normalised to actin mRNA levels. 
Data are presented in % of control (mean ± SEM of n=6-9). 
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